Influenza B virus neuraminidase: a potential target for next-generation vaccines? THT Do, AK Wheatley, SJ Kent, M Koutsakos Expert Review of Vaccines 23 (1), 39-48, 2024 | 2 | 2024 |
Immune imprinting in early life shapes cross-reactivity to influenza B virus haemagglutinin P Edler, LSU Schwab, M Aban, M Wille, N Spirason, YM Deng, ... Nature Microbiology, 1-11, 2024 | | 2024 |
Dissemination of influenza B virus to the lower respiratory tract of mice is restricted by the interferon response LSU Schwab, THT Do, D Pilapitiya, M Koutsakos Journal of Virology 98 (6), e01604-23, 2024 | | 2024 |
Is eradication of influenza B viruses possible? M Koutsakos, S Rockman, F Krammer The Lancet. Infectious diseases 24 (5), 451-453, 2024 | | 2024 |
Characterisation of novel influenza‐derived HLA‐B* 18: 01‐restricted epitopes SL Leong, L Murdolo, JC Maddumage, M Koutsakos, K Kedzierska, ... Clinical & Translational Immunology 13 (5), e1509, 2024 | | 2024 |
Durable reprogramming of neutralizing antibody responses following Omicron breakthrough infection WS Lee, HX Tan, A Reynaldi, R Esterbauer, M Koutsakos, J Nguyen, ... Science Advances 9 (29), eadg5301, 2023 | 11 | 2023 |
Immunological imprinting: understanding COVID-19 M Koutsakos, AH Ellebedy Immunity 56 (5), 909-913, 2023 | 37 | 2023 |
SARS-CoV-2 breakthrough infection induces rapid memory and de novo T cell responses M Koutsakos, A Reynaldi, WS Lee, J Nguyen, T Amarasena, G Taiaroa, ... Immunity 56 (4), 879-892. e4, 2023 | 58 | 2023 |
Prime-boost, double-dose influenza vaccine immunity in COPD: a pilot observational study GP Anderson, LB Irving, A Jarnicki, K Kedzierska, M Koutsakos, S Kent, ... ERJ Open Research 9 (2), 2023 | 1 | 2023 |
Differential cross-reactivity to the influenza B virus haemagglutinin underpins lineage-specific susceptibility between birth cohorts P Edler, LSU Schwab, M Aban, M Wille, N Spirason, YM Deng, ... bioRxiv, 2023.08. 25.554879, 2023 | 2 | 2023 |
Assessment of antibodies in the upper and lower human respiratory tract at steady state and after respiratory viral infection M Koutsakos, JS Turner, MCV Guillamet, D Reynolds, T Lei, DE Byers, ... Clinical & Translational Immunology 12 (8), e1460, 2023 | 2 | 2023 |
Robust immunity to influenza vaccination in haematopoietic stem cell transplant recipients following reconstitution of humoral and adaptive immunity W Zhang, LC Rowntree, R Muttucumaru, T Damelang, M Aban, AC Hurt, ... Clinical & Translational Immunology 12 (6), e1456, 2023 | 3 | 2023 |
Rapid recall andde novoT cell responses during SARS-CoV-2 breakthrough infection M Koutsakos, A Reynaldi, WS Lee, J Nguyen, T Amarasena, G Taiaroa, ... | | 2022 |
Rapid recall and de novo T cell responses during SARS-CoV-2 breakthrough infection M Koutsakos, A Reynaldi, WS Lee, J Nguyen, T Amarasena, G Taiaroa, ... bioRxiv, 2022.12. 19.521129, 2022 | 1 | 2022 |
Methods and compositions for preventing influenza infection M Koutsakos, K Kedzierska, EB CLEMENS, L Hensen US Patent 11,517,617, 2022 | | 2022 |
Immunization with inactivated whole virus particle influenza virus vaccines improves the humoral response landscape in cynomolgus macaques BY Chua, T Sekiya, M Koutsakos, N Nomura, LC Rowntree, THO Nguyen, ... PLoS pathogens 18 (10), e1010891, 2022 | 2 | 2022 |
SATB1 ensures appropriate transcriptional programs within naïve CD8+ T cells S Nüssing, LA Miosge, K Lee, M Olshansky, A Barugahare, CM Roots, ... Immunology and Cell Biology 100 (8), 636-652, 2022 | 5 | 2022 |
The magnitude and timing of recalled immunity after breakthrough infection is shaped by SARS-CoV-2 variants M Koutsakos, WS Lee, A Reynaldi, HX Tan, G Gare, P Kinsella, KC Liew, ... Immunity 55 (7), 1316-1326. e4, 2022 | 43 | 2022 |
Long live the plasma cell: the basis of sustained humoral immunity M Koutsakos, AH Ellebedy The Journal of Immunology 209 (1), 3-4, 2022 | 2 | 2022 |
Establishment and recall of SARS-CoV-2 spike epitope-specific CD4+ T cell memory KM Wragg, WS Lee, M Koutsakos, HX Tan, T Amarasena, A Reynaldi, ... Nature Immunology 23 (5), 768-780, 2022 | 55 | 2022 |